Degradation of cIAP1 and cIAP2 in cancer cells allows for the accumulation of nuclear factor-κB (NF-κB)-inducing kinase (NIK) and stimulates the activation of the non-canonical NF-κB pathway [67]. Here, BIRC3 is linked to cancer.